ANSELL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.75 AUD | +2.02% |
|
+2.71% | +2.26% |
| Apr. 15 | Ansell Launches AU$65 Million Share Purchase Plan | MT |
| Apr. 10 | JPMorgan Upgrades Ansell to Overweight from Neutral, Price Target is AU$29.20 | MT |
| Sales 2024 * | 1.63B 2.53B | Sales 2025 * | 1.92B 2.97B | Capitalization | 2.3B 3.56B |
|---|---|---|---|---|---|
| Net income 2024 * | 81M 126M | Net income 2025 * | 157M 243M | EV / Sales 2024 * | 1.57 x |
| Net Debt 2024 * | 265M 411M | Net Debt 2025 * | 457M 708M | EV / Sales 2025 * | 1.44 x |
| P/E ratio 2024 * |
28.1
x | P/E ratio 2025 * |
14.3
x | Employees | 14,000 |
| Yield 2024 * |
2.35% | Yield 2025 * |
2.82% | Free-Float | 98.13% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ansell Limited
More recommendations
More press releases
More news
| 1 day | +2.06% | ||
| 1 week | +3.25% | ||
| Current month | +4.80% | ||
| 1 month | +6.23% | ||
| 3 months | +6.84% | ||
| 6 months | +18.38% | ||
| Current year | +2.30% |
1 week
24.40
25.81
1 month
23.5827.49
Current year
22.5127.49
1 year
21.0027.91
3 years
21.0044.07
5 years
20.1944.07
10 years
14.7644.07
| Managers | Title | Age | Since |
|---|---|---|---|
Neil Salmon
CEO | Chief Executive Officer | 55 | 13-07-14 |
Zubair Javeed
DFI | Director of Finance/CFO | - | 19-04-22 |
John Marsden
COO | Chief Operating Officer | - | 19-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ying Yan
BRD | Director/Board Member | 58 | 19-03-31 |
Nigel Garrard
CHM | Chairman | 63 | 20-02-29 |
William Reilly
BRD | Director/Board Member | - | 99-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 1,120 M€ | -0.04% | ||
| 0.02% | 773 M€ | -.--% | - | |
| 0.01% | 7 M€ | +1.02% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 25.75 | +2.02% | 666 983 |
| 24-04-22 | 25.24 | +2.06% | 390,291 |
| 24-04-19 | 24.73 | -0.32% | 738,711 |
| 24-04-18 | 24.81 | -0.40% | 486,860 |
| 24-04-17 | 24.91 | -0.16% | 257,763 |
Delayed Quote Australian S.E., April 23, 2024 at 01:59 am EDT
More quotes
Ansell Limited is an Australia-based provider of hand and body protection solutions and an integrated manufacturer, innovator and marketer of products. The Company is principally involved in the development, manufacturing and sourcing, distribution and sale of hand and body protection solutions in the industrial and healthcare markets. It provides protection solutions to approximately 25 specific industries and protects approximately 10 million workers each day. The Company operates through two segments: Industrial Global Business Unit (GBU) and Healthcare Global Business Unit (GBU). Healthcare GBU segment is engaged in surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single-use industrial application gloves. Industrial GBU segment is engaged in multi-use hand and body protection solutions for industrial work environments and specialty applications.
Calendar
2024-08-19
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.25
USD
Average target price
17.81
USD
Spread / Average Target
+9.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.30% | 2.3B | |
| -2.73% | 186B | |
| -2.20% | 107B | |
| -4.08% | 67.57B | |
| +5.99% | 50.7B | |
| +15.32% | 47.2B | |
| -0.45% | 39.72B | |
| +6.60% | 27.48B | |
| -1.11% | 25.65B | |
| -0.76% | 24.82B |
- Stock Market
- Equities
- ANN Stock
